| Autor: |
Breuer JA; School of Medicine, University of California Irvine, Irvine, USA.; Department of Radiological Sciences, University of California Irvine, Orange, USA., Ahmed KH; School of Medicine, University of California Irvine, Irvine, USA.; Department of Radiological Sciences, University of California Irvine, Orange, USA., Al-Khouja F; School of Medicine, University of California Irvine, Irvine, USA.; Department of Radiological Sciences, University of California Irvine, Orange, USA., Macherla AR; School of Medicine, University of California Irvine, Irvine, USA.; Department of Radiological Sciences, University of California Irvine, Orange, USA., Muthoka JM; School of Medicine, University of California Irvine, Irvine, USA.; Department of Radiological Sciences, University of California Irvine, Orange, USA., Abi-Jaoudeh N; Department of Radiological Sciences, University of California Irvine, Orange, USA. |
| Abstrakt: |
Interventional oncology is a rapidly emerging field in the treatment of cancer. Minimally invasive techniques such as transarterial embolization with chemotherapeutic and radioactive agents are established therapies and are found in multiple guidelines for the management of primary and metastatic liver lesions. Percutaneous ablation is also an alternative to surgery for small liver, renal, and pancreatic tumors. Recent research in the niche of interventional oncology has focused on improving outcomes of established techniques in addition to the development of novel therapies. In this review, we address the recent and current advancements in devices, technologies, and techniques of chemoembolization and ablation: thermal ablation, histotripsy, high-intensity focused ultrasound, embolization strategies, liquid embolic agents, and local immunotherapy/antiviral therapies. |
